Use of Fecal Microbiota for Transplantation Comes with Serious Risk, Says FDA

March 18, 2020 | Strategic Insights for Health System


What's the news. The use of fecal microbiota for transplantation (FMT) to treat Clostridioides difficile comes with the risk for serious or life-threatening illnesses, the U.S. Food and Drug Administration (FDA) announced in a March 12, 2020, safety communication.

Access Full Content

Contact us today at 610.825.6000.